Establishment of Human PD-1/PD-L1 Blockade Assay Based on Surface Plasmon Resonance (SPR) Biosensor

Blockade of the programmed cell death protein 1 (PD-1)/PD-ligand 1 (PD-L1) axis is a promising strategy for cancer immunotherapy. Although antibody-based PD-1/PD-L1 inhibitors have shown remarkable results in clinical cancer studies, their inherent limitations underscore the significance of developi...

Descripción completa

Detalles Bibliográficos
Autores principales: Puopolo, Tess, Li, Huifang, Gutkowski, Justin, Cai, Ang, Seeram, Navindra P., Ma, Hang, Liu, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bio-Protocol 2023
Materias:
Methods Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415205/
https://www.ncbi.nlm.nih.gov/pubmed/37575393
http://dx.doi.org/10.21769/BioProtoc.4765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415205/
https://www.ncbi.nlm.nih.gov/pubmed/37575393
http://dx.doi.org/10.21769/BioProtoc.4765

Ejemplares similares